Gilead Sciences (GILD) Updates on Study 102 for TAF on HIV-1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. KNX
6. CSX
7. GOOG
8. IBM
9. LVS
10. GSHD

Go back to Gilead Sciences (GILD) Updates on Study 102 for TAF on HIV-1
Gilead Sciences (NASDAQ: GILD) Delayed: 128.56 -1.78 (1.37%)
Previous Close $130.34    52 Week High $108.63 
Open $129.22    52 Week Low $71.39 
Day High $129.59    P/E 71.03 
Day Low $127.61    EPS $1.81 
Volume 292,957